No paralogue variants have been mapped to residue 128 for CACNA1C.
| CACNA1C | TRPPRALLCLTLKNPIRRACISIVEWKPFE>I<IILLTIFANCVALAIYIPFPEDDSNATNSN | 158 |
| CACNA1A | LTVNRSLFLFSEDNVVRKYAKKITEWPPFE>Y<MILATIIANCIVLALEQHLPDDDKTPMSER | 132 |
| CACNA1B | FTVNRSLFVFSEDNVVRKYAKRITEWPPFE>Y<MILATIIANCIVLALEQHLPDGDKTPMSER | 129 |
| CACNA1D | SRPARALFCLSLNNPIRRACISIVEWKPFD>I<FILLAIFANCVALAIYIPFPEDDSNSTNHN | 160 |
| CACNA1E | FTVNRSLFIFGEDNIVRKYAKKLIDWPPFE>Y<MILATIIANCIVLALEQHLPEDDKTPMSRR | 123 |
| CACNA1F | QRSPRALFCLTLANPLRRSCISIVEWKPFD>I<LILLTIFANCVALGVYIPFPEDDSNTANHN | 126 |
| CACNA1G | ALAPVVFFYLSQDSRPRSWCLRTVCNPWFE>R<ISMLVILLNCVTLGMFRPCEDIACDSQRCR | 115 |
| CACNA1H | ALAATVFFCLGQTTRPRSWCLRLVCNPWFE>H<VSMLVIMLNCVTLGMFRPCEDVECGSERCN | 134 |
| CACNA1I | DLAPIAFFCLRQTTSPRNWCIKMVCNPWFE>C<VSMLVILLNCVTLGMYQPCDDMDCLSDRCK | 113 |
| CACNA1S | PRPPRALFCLTLENPLRKACISIVEWKPFE>T<IILLTIFANCVALAVYLPMPEDDNNSLNLG | 85 |
| SCN10A | FSATRALWLFSPFNLIRRTAIKVSVHSWFS>L<FITVTILVNCVCMTRT------D-LPE--- | 154 |
| SCN11A | FSAKHALFIFGPFNSIRSLAIRVSVHSLFS>M<FIIGTVIINCVFMATGPA-K--NSNSNNT- | 159 |
| SCN1A | FSATSALYILTPFNPLRKIAIKILVHSLFS>M<LIMCTILTNCVFMTMS------N-PPDWT- | 154 |
| SCN2A | FSATPALYILTPFNPIRKLAIKILVHSLFN>M<LIMCTILTNCVFMTMS------N-PPDWT- | 155 |
| SCN3A | FSATSALYILTPLNPVRKIAIKILVHSLFS>M<LIMCTILTNCVFMTLS------N-PPDWT- | 154 |
| SCN4A | FSATPALYLLSPFSVVRRGAIKVLIHALFS>M<FIMITILTNCVFMTMS------D-PPPWS- | 157 |
| SCN5A | FSATNALYVLSPFHPIRRAAVKILVHSLFN>M<LIMCTILTNCVFMAQH------D-PPPWT- | 157 |
| SCN7A | FNAASILCTLSPFNCIRRTTIKVLVHPFFQ>L<FILISVLIDCVFMSLT------N-LPKWR- | 144 |
| SCN8A | FSATPALYILSPFNLIRRIAIKILIHSVFS>M<IIMCTILTNCVFMTFS------N-PPDWS- | 158 |
| SCN9A | FNATPALYMLSPFSPLRRISIKILVHSLFS>M<LIMCTILTNCIFMTMN------N-PPDWT- | 152 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.I128V | c.382A>G | Putative Benign | SIFT: Polyphen: |